Skip to main content

Michael H. Pillinger, MD

  • Specialty: Rheumatology
  • Language: English

Credentials

Positions
  • Professor, Department of Medicine
  • Professor, Department of Biochemistry and Molecular Pharmacology
  • Chief of Rheumatology, VA NY Harbor Health Care System
  • Director, Rheumatology Fellowship Program
  • Director, Clinical and Translational Science Institute Education and Careers Unit
Education and Training
  • Fellowship, New York University School of Medicine, Rheumatology, 1993
  • Residency, Jacobi Medical Center, Internal Medicine, 1990

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Research My Research

Interests

signal transduction and the regulation of cells involved in inflammation and rheumatoid arthritis

Research Summary

In rheumatoid arthritis (RA) the tissues of the involved joints assume inflammatory, autoimmune and pseudoneoplastic features. The cells contributing to these phenotypes include neutrophils, which accumulate in the RA joint space, and synovial fibroblasts (SFs), which proliferate in great numbers in the RA synovium (pannus) and secrete matrix metalloproteinases (MMPs) that participate in the destruction of cartilage.
The mitogen-activated protein kinases (MAPKs) include the Erks, Jnks and p38. Our laboratory is interested in the role of MAPKs on neutrophils and SF regulation. We are especially interested in the role of Erks. We have observed that, in neutrophils, Erk is rapidly activated in response to chemoattractants and regulates neutrophil adhesion, a critical early step in the acute inflammation. In SFs we have shown that Erk regulates proliferation, but also the release of some (MMP-1,3,9) but not other (MMP-13) metalloproteinases. Interestingly, high-dose salicylates (doses achievable in patients but in excess of those needed to inhibit cyclooxygenase) inhibit Erk in both neutrophils and SFs, and concordantly inhibit neutrophil adhesion and SF MMP release. Non-salicylate nonsteroidals also inhibit cyclooxygenase but do not reproduce these effects. Indeed, COX inhibition actually leads to enhancement of MMP release from synovial fibroblasts.
Our present aims are threefold: 1) to understand the mechanisms through which Erk positively regulates neutrophil adhesion; 2) to understand the cross talk between prostaglandin production and Erk activation in SF responses; 3) to understand the mechanisms through which salicylates inhibit Erk, as a clue into how Erk, and other signaling pathways, may be pharmacologically targeted. A better understanding of these phenomena may lead to new approaches, and new agents, for the treatment of RA.}

Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library.
represents one publication
Loading...

Clinical Trials and Research Studies

  • An observational study assessing the prevalence of lumbosacral spinal urate deposition in patients with tophaceous and non-tophaceous gout compared with non-gout controls using Dual-Energy CT (DECT)

    Learn More
View All Research Studies (1)

Publications

Read All Publications (175)

Related News

We can help you find a doctor. Call 646-929-7800 or
browse our specialists.